ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.230
+0.050 (1.20%)
At close: Dec 12, 2025, 4:00 PM EST
4.100
-0.130 (-3.07%)
After-hours: Dec 12, 2025, 7:11 PM EST
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $524 million as of December 12, 2025. Its market cap has increased by 144.12% in one year.
Market Cap
524.00M
Enterprise Value
746.70M
1-Year Change
144.12%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $524.00M, a decrease of -74.35%. That is a compound annual growth rate of -21.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 524.00M | 172.33% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |